StrideBio
Pre-clinicalDevelops engineered adeno-associated virus vectors for gene therapies targeting genetic diseases.
Founded
2015
Focus
RNA & Gene Therapy
About
Develops engineered adeno-associated virus vectors for gene therapies targeting genetic diseases.
Funding History
3Total raised: $166.5M
Series B$80MNorthpond VenturesJun 15, 2021
Series A$81.5MNorthpond VenturesJun 15, 2019
Seed$5MHatteras Venture PartnersJun 15, 2017
Company Info
TypePrivate
Founded2015
LocationDurham, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile